Study Stopped
Determined not to be Human Subject Research
Environmental and Genetic Determinants of NPC
2 other identifiers
observational
3,500
1 country
6
Brief Summary
Background: \- Nasopharyngeal carcinoma (NPC) a common malignant tumor in southern China and Southeast Asia. Infection with Epstein-Barr virus is believed to be necessary for the development of NPC; non-viral environmental factors, such as dietary consumption of nitrosamines, cigarette smoking, betel nut chewing, wood dust exposure and possibly exposure to formaldehyde, have been implicated in the disease. Genetic susceptibility may also play an important role in the development of NPC. However, more information is needed on the connections between genetic and environmental factors in NPC, particularly in areas where the cancer risk appears to be greatest. Objectives: \- To examine the main effects of genetic factors and environmental exposures (e.g., cigarette smoking, betel nut chewing, formaldehyde, wood dust) on nasopharyngeal carcinoma risk. Eligibility:
- Cases: Individuals at least 21 years of age who have been diagnosed with NPC at one of the participating hospitals and have been residents of northern Taiwan for at least 6 months.
- Controls: Hospital patients with diseases other than NPC at least 21 years of age, matched to NPC patients based on hospital, age at diagnosis, gender, and ethnicity. Design:
- This study involves a risk factor interview, medical record abstraction and biological sample collection.
- Participants will respond to interview questions about their lifestyle and risk factors thought to be involved in NPC development.
- All participants will provide blood and saliva samples for study. Participants who have been diagnosed with NPC will also provide consent to allow researchers to study tissue samples taken during tumor biopsies or surgeries.
- Treatment will not be provided as part of this protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2010
Longer than P75 for all trials
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2010
CompletedStudy Start
First participant enrolled
December 8, 2010
CompletedFirst Posted
Study publicly available on registry
December 9, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 2, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 2, 2020
CompletedJune 4, 2020
June 1, 2020
9.5 years
December 8, 2010
June 3, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Nasopharyngeal carcinoma
NPC diagnosis
Study Arms (2)
Cases with NPC
Cases with NPC
Hospital based controls
Hospital based controls
Eligibility Criteria
This is a hospital based case control population
You may qualify if:
- Eligibility criteria for cases:
- Incident diagnosis of NPC between 2010-2015
- Age greater than or equal to 21 years at NPC diagnosis
- Histologically confirmed
- Resident of northern Taiwan greater than or equal to 6 months
- Eligibility criteria for controls:
- Resident of northern Taiwan greater than or equal to 6 months
- Matched to case based on age at diagnosis, gender, and ethnicity
You may not qualify if:
- \- Clinic attendance due to conditions associated with EBV or smoking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Cancer Institute (NCI)lead
- Academia Sinica, Taiwancollaborator
- National Taiwan University Hospitalcollaborator
- Koo Foundation Sun Yat-Sen Cancer Centercollaborator
- Mackay Memorial Hospitalcollaborator
- Far Easter Memorial Hospitalcollaborator
- Cathay General Hospitalcollaborator
Study Sites (6)
Academia Sinica 128 Academia Road
Taipei, Taiwan
Cathay General Hospital 280 Renai Rd, Section 4
Taipei, Taiwan
Far Easter Memorial Hospital 21, NanYa S. Rd, Section 2, Ban-Chiao
Taipei, Taiwan
Koo Foundation Sun Yat-Sen Cancer Center
Taipei, Taiwan
MacKay Memorial Hospital No 92, Section 2, Zhongshan N. Rd, Zhongshan Dist
Taipei, Taiwan
National Taiwan University Hospital
Taipei, Taiwan
Related Publications (3)
Armstrong RW, Imrey PB, Lye MS, Armstrong MJ, Yu MC, Sani S. Nasopharyngeal carcinoma in Malaysian Chinese: salted fish and other dietary exposures. Int J Cancer. 1998 Jul 17;77(2):228-35. doi: 10.1002/(sici)1097-0215(19980717)77:23.0.co;2-7.
PMID: 9650558BACKGROUNDBei JX, Li Y, Jia WH, Feng BJ, Zhou G, Chen LZ, Feng QS, Low HQ, Zhang H, He F, Tai ES, Kang T, Liu ET, Liu J, Zeng YX. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet. 2010 Jul;42(7):599-603. doi: 10.1038/ng.601. Epub 2010 May 30.
PMID: 20512145BACKGROUNDBlair A, Saracci R, Stewart PA, Hayes RB, Shy C. Epidemiologic evidence on the relationship between formaldehyde exposure and cancer. Scand J Work Environ Health. 1990 Dec;16(6):381-93. doi: 10.5271/sjweh.1767.
PMID: 2284588BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Allan Hildesheim, Ph.D.
National Cancer Institute (NCI)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- OTHER
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 8, 2010
First Posted
December 9, 2010
Study Start
December 8, 2010
Primary Completion
June 2, 2020
Study Completion
June 2, 2020
Last Updated
June 4, 2020
Record last verified: 2020-06